Results 31 to 40 of about 2,783 (213)

Onchocerciasis identified with anterior segment ocular examination and FDG-PET/CT imaging

open access: yesClinical Infection in Practice
Background: Ocular onchocerciasis, commonly known as “river blindness,” is a parasitic infection caused by the filarial nematode Onchocerca volvulus. Although presentation within the United Kingdom is extremely rare, with no reports evident within the ...
Benjamin Griffin   +4 more
doaj   +1 more source

Autochthonous, zoonotic Onchocerca lupi in a South Texas dog, United States

open access: yesParasites & Vectors, 2021
Background Onchocerca lupi is an emerging, zoonotic filarioid nematode associated with ocular disease in companion animals in North America and the Old World. The areas where this parasite is assumed to be endemic in the USA comprise southwestern states.
Guilherme G. Verocai   +4 more
doaj   +1 more source

Ivermectin for onchocercal eye disease (river blindness).

open access: yes, 2012
BACKGROUND: It is believed that ivermectin (a microfilaricide) could prevent blindness due to onchocerciasis. However, when given to everyone in communities where onchocerciasis is common, the effects of ivermectin on lesions affecting the eye are ...
Ejere, Henry OD   +3 more
core   +1 more source

Redescription of Onchocerca lupi (Spirurida: Onchocercidae) with histopathological observations [PDF]

open access: yes, 2013
BACKGROUND: Onchocerca lupi is a dog parasite of increasing zoonotic concern, with new human cases diagnosed in Turkey, Tunisia, Iran, and the United States. Information about the morphology of this nematode is scant and a detailed re-description of this
Alessio Giannelli   +7 more
core   +1 more source

Health-related quality of life and associated factors among Onchocerciasis patients in southeast Nigeria: A cross-sectional comparative study

open access: yesPLoS Neglected Tropical Diseases, 2022
Introduction Onchocerciasis, a neglected tropical disease of public health importance, causes chronic morbidity and severe disability that may impact on health-related quality of life (HRQoL) of the infected people.
Adah E. Otache   +5 more
doaj  

Prevalence of onchocerciasis and associated clinical manifestations in selected hypoendemic communities in Ghana following long-term administration of ivermectin

open access: yesBMC Infectious Diseases, 2019
Background Onchocerciasis is a neglected tropical disease which is still of immense major public health concern in several areas of Africa and the Americas.
Kenneth Bentum Otabil   +11 more
doaj   +1 more source

Human filarial Wolbachia lipopeptide directly activates human neutrophils in vitro. [PDF]

open access: yes, 2014
The host inflammatory response to the Onchocerca volvulus endosymbiont, Wolbachia, is a major contributing factor in the development of chronic pathology in humans (onchocerciasis/river blindness).
Edwards, Steven W   +5 more
core   +1 more source

Prevalence of onchocerciasis after seven years of continuous community-directed treatment with ivermectin in the Ntui health district, Centre region, Cameroon

open access: yesThe Pan African Medical Journal, 2020
INTRODUCTION: Onchocerciasis is one of the major infectious diseases caused by Onchocerca volvulus. This parasite is responsible for chronic cutaneous and ocular diseases affecting more than 37 million people of whom 99% are in Africa.
Estelle Makou Tsapi   +4 more
doaj   +1 more source

Factors affecting onchocerciasis transmission: Lessons for infection control [PDF]

open access: yes, 2017
Introduction: Onchocerca volvulus infects in excess of 15 million people. The vectors are Simulium blackflies, varieties of which differ in their ecologies, behaviour and vectorial abilities.
Cheke, Robert A.
core   +1 more source

Ivermectin Toxicity in Humans and Animals: Clinical Spectrum, Mechanisms, and Management

open access: yesJournal of Applied Toxicology, Volume 46, Issue 6, Page 1856-1870, June 2026.
ABSTRACT Ivermectin is a widely used macrocyclic lactone with established efficacy against a broad range of parasitic infections in humans and animals and a long‐standing reputation for clinical safety. However, increasing evidence indicates that ivermectin can produce clinically relevant toxicity under specific conditions, particularly involving the ...
Serkan Yilmaz   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy